Category Archives: 2025

Adv. Synth. Cat. 2025

Synthesis of Polysubstituted Naphthalenes via Metal-Free Borylative Cyclization of o-Alkynylstyrenes

Marcos Humanes, Manuel A. Fernández-Rodríguez,* Patricia García-García*

A selective, metal-free method for the synthesis of boron-functionalized polysubstituted naphthalenes via BCl3-mediated cyclization of α-substituted o-alkynylstyrenes is described. The reaction exhibits broad substrate scope, tolerating various groups such as ethers, sulfides and halogens, and delivers high yields under mild conditions, even at gram scale. The resulting Bpin-functionalized naphthalenes serve as versatile building blocks, facilitating further transformations of the C−B bond into C−H, C−C, C−I, C−O, and C−N bonds, thereby increasing molecular complexity and enabling the design of more functionalized products. Notably, this sustainable and straightforward protocol selectively introduces the Bpin group at the sterically hindered α-carbon of the naphthalene framework, complementing C–H borylations of the naphthalene core, that preferentially occur at the β-position. As a result, the developed approach significantly broadens the accessibility of B-functionalized naphthalene derivatives for synthetic and application-oriented purposes.

Adv. Synth. Cat. 2025
DOI: 10.1002/adsc.202500244

Maqueda-Zelaya et al. Arch Pharm (Weinheim). 2025;358(1):e2400614. Identification and study of new NF-κB-inducing kinase ligands derived from the imidazolone scaffold.

Publications > Maqueda-Zelaya et al

Identification and study of new NF-κB-inducing kinase ligands derived from the imidazolone scaffold.

1. Departamento de Química Orgánica y Química Inorgánica, Instituto de Investigación Química "Andrés M. Del Río" (IQAR), Universidad de Alcalá (IRYCIS), Alcalá de Henares, Madrid, Spain.  2. Departamento de Nefrología e Hipertensión, IIS-Fundación Jiménez Díaz UAM, Madrid, Spain.  3. RICORS2040, Madrid, Spain.

Abstract

Chronic kidney disease (CKD) is a growing health concern, projected to be a major cause of death by 2040, due to an increasing risk of acute kidney injury (AKI). Systems biology-derived data suggest that the unmet need for an orally available drug to treat AKI and improve CKD outcomes may be addressed by targeting kidney inflammation and, specifically, nuclear factor κB-inducing kinase (NIK), a key signaling molecule that activates the noncanonical nuclear factor κB (NF-κB) pathway. We have prepared and identified a small family of imidazolone derivatives that bind NIK and inhibit the noncanonical NF-κB activation pathway. The introduction of heterocyclic substituents in position 2 of the imidazolone core provides compounds with affinity against human NIK. Three candidates, with best affinity profile, were tested in phenotypic experiments of noncanonical NF-κB activation, confirming that the derivative bearing the 4-pyridyl ring can inhibit the processing of NFκB p100 to NFkB2 p52, which is NIK-dependent in cultured kidney tubular cells. Finally, exhaustive docking calculations combined with molecular dynamics studies led us to propose a theoretical binding mode and rationalize affinity measures, in which the aminopyridine motif is a key anchoring point to the hinge region thanks to several hydrogen bonds and the interaction of heterocyclic rings in position 2 with Ser476 and Lys482. Our result will pave the way for the development of potential drug candidates targeting NIK in the context of CKD.

Mañas and. Advanced Synthesis & Catalysis. 2025;367(1):e202400990. Combined Gold and Photoredox Catalysis: Synthesis of 3-Alkenyl-2H-Indazoles from 2-Alkynylazobenzenes.

Publications > Mañas and

Combined Gold and Photoredox Catalysis: Synthesis of 3-Alkenyl-2H-Indazoles from 2-Alkynylazobenzenes.

Resumen

No hay resumen